tradingkey.logo

Takeda Pharmaceutical Co Ltd

TAK
View Detailed Chart

15.025USD

-0.084-0.56%
Close 04/25, 16:00ETQuotes delayed by 15 min
23.82BMarket Cap
0.11P/E TTM

Takeda Pharmaceutical Co Ltd

15.025

-0.084-0.56%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.56%

5 Days

+2.14%

1 Month

+0.64%

6 Months

+10.72%

Year to Date

+13.48%

1 Year

+15.31%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts
BUY
Current Rating
17.433
Target Price
15.99%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
8
Average
Company name
Ratings
Analysts
Takeda Pharmaceutical Co Ltd
TAK
4
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
32

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(3)
Neutral(3)
Buy(6)
Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.087
Buy
RSI(14)
58.384
Neutral
STOCH(KDJ)(9,3,3)
82.006
Neutral
ATR(14)
0.392
Low Volatility
CCI(14)
69.892
Neutral
Williams %R
17.579
Overbought
TRIX(12,20)
0.134
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
15.116
Sell
MA10
14.766
Buy
MA20
14.697
Buy
MA50
14.249
Buy
MA100
13.796
Buy
MA200
13.928
Buy

News

More news coming soon, stay tuned...

Company

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Company codeTAK
CompanyTakeda Pharmaceutical Co Ltd
CEOMr. Christophe Weber
Websitehttps://www.takeda.com/